Breakdown | ||||
Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | Jun 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
0.00 | 5.79K | 3.15K | 10.94K | 0.00 | Gross Profit |
-14.73K | -12.39K | -31.34K | -23.27K | -22.28K | EBIT |
-2.91M | -3.26M | -2.06M | -2.04M | -2.78M | EBITDA |
-2.91M | -2.92M | -2.84M | -2.10M | -3.37M | Net Income Common Stockholders |
-3.12M | -3.20M | -2.88M | -2.11M | -3.98M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
425.96K | 3.27M | 1.01M | 3.12M | 1.29M | Total Assets |
21.89M | 17.36M | 12.41M | 14.01M | 9.74M | Total Debt |
0.00 | 3.46M | 3.22M | 2.53M | 91.80K | Net Debt |
-425.96K | 196.81K | 2.21M | -588.15K | -1.20M | Total Liabilities |
6.08M | 6.50M | 6.07M | 4.90M | 2.20M | Stockholders Equity |
15.81M | 10.86M | 6.34M | 9.11M | 7.54M |
Cash Flow | Free Cash Flow | |||
-5.50M | -4.72M | -3.31M | -2.95M | -5.44M | Operating Cash Flow |
-1.20M | -1.78M | -1.60M | -1.71M | -3.71M | Investing Cash Flow |
-3.82M | -2.95M | -2.70M | -2.08M | 2.21M | Financing Cash Flow |
2.18M | 6.98M | 2.18M | 5.62M | 2.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
49 Neutral | $1.96B | -1.23 | -21.20% | 3.72% | 0.95% | -28.96% | |
45 Neutral | AU$404.72M | ― | -5.89% | ― | ― | 63.46% | |
40 Underperform | AU$2.94M | ― | -149.92% | ― | ― | 32.43% | |
34 Underperform | AU$2.51M | ― | ― | 72.25% | 56.91% | ||
31 Underperform | $28.60M | ― | -44.65% | ― | ― | -69.23% |
Avenira Limited has announced key developments for the quarter ending March 2025, including the expected site mobilisation for the Wonarah Phosphate Project in May/June, with mining to commence in Q3 and the first shipment in Q4. The company has secured significant investment from Sichuan Hebang Technology and re-engaged experienced mining executive Sean Buxton to lead operations. The revised Mining Management Plan for the project has been accepted with minor changes and is under final review by Northern Territory regulators. These strategic moves are part of Avenira’s efforts to achieve near-term cashflow and establish a foundation for long-term growth.
Avenira Limited has announced a proposed issue of up to 1,081,000,000 ordinary fully paid securities, with the issuance date set for May 30, 2025. This move is part of a placement or other type of issue, which could potentially impact the company’s market positioning by increasing its capital base, thereby supporting its operational and strategic initiatives.
Avenira Limited has secured a significant investment from its largest shareholder, Hebang Biotechnology, which includes a placement of A$7.567 million and an unsecured loan facility. This investment aims to accelerate the DSO Project, enhancing the value of Avenira’s Wonarah resource and demonstrating Hebang’s commitment to Avenira’s success.
Avenira Limited announced the termination of its License and Technology Transfer Agreement with Advanced Lithium Electrochemistry Co Ltd due to evolving market conditions, which releases both parties from any further claims or liabilities. This strategic move allows Avenira to concentrate on its Wonarah Project, which involves phased development strategies to generate early revenue by late 2025, and aims to expand into the global market with sustainable growth through a diversified product portfolio.